Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Journal of Hematology & Oncology
|
July 29, 2020
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
Yonghan He, Sajid Khan, Zhiguang Huo, et al.
Tetrahedron
|
October 25, 2016
Synthesis of (2<i>R</i>,8' <i>S</i>,3' <i>E</i>)-δ-tocodienol, a tocoflexol family member designed to have a superior pharmacokinetic profile compared to δ-tocotrienol
Xingui Liu, Satheesh Gujarathi, Xuan Zhang, et al.
Life Sciences in Space Research
|
October 25, 2021
Mitigation of late cardiovascular effects of oxygen ion radiation by γ-tocotrienol in a mouse model
Ashley S Nemec-Bakk, Vijayalakshmi Sridharan, Reid D Landes, et al.
Frontiers in Cell and Developmental Biology
|
April 29, 2021
Expression Level of ADAMTS1 in Granulosa Cells of PCOS Patients Is Related to Granulosa Cell Function, Oocyte Quality, and Embryo Development
Guang Yang, Guidong Yao, Ziwen Xu, et al.
Journal of Medicinal Chemistry
|
September 17, 2021
Discovery of a Novel BCL-X<sub>L</sub> PROTAC Degrader with Enhanced BCL-2 Inhibition
Pratik Pal, Dinesh Thummuri, Dongwen Lv, et al.
Journal of the American Chemical Society
|
August 25, 2022
Discovery of XL01126: A Potent, Fast, Cooperative, Selective, Orally Bioavailable, and Blood-Brain Barrier Penetrant PROTAC Degrader of Leucine-Rich Repeat Kinase 2
Xingui Liu, Alexia F Kalogeropulou, Sofia Domingos, et al.
Aging Cell
|
May 17, 2018
Oxidation resistance 1 is a novel senolytic target
Xin Zhang, Suping Zhang, Xingui Liu, et al.
Cell Chemical Biology
|
February 7, 2023
Piperlongumine conjugates induce targeted protein degradation
Jing Pei, Yufeng Xiao, Xingui Liu, et al.
Nature Communications
|
April 26, 2020
Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity
Yonghan He, Xuan Zhang, Jianhui Chang, et al.
Nature Communications
|
November 26, 2021
Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity
Dongwen Lv, Pratik Pal, Xingui Liu, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Journal of Hematology & Oncology
|
July 29, 2020
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
Yonghan He, Sajid Khan, Zhiguang Huo, et al.
Tetrahedron
|
October 25, 2016
Synthesis of (2<i>R</i>,8' <i>S</i>,3' <i>E</i>)-δ-tocodienol, a tocoflexol family member designed to have a superior pharmacokinetic profile compared to δ-tocotrienol
Xingui Liu, Satheesh Gujarathi, Xuan Zhang, et al.
Life Sciences in Space Research
|
October 25, 2021
Mitigation of late cardiovascular effects of oxygen ion radiation by γ-tocotrienol in a mouse model
Ashley S Nemec-Bakk, Vijayalakshmi Sridharan, Reid D Landes, et al.
Frontiers in Cell and Developmental Biology
|
April 29, 2021
Expression Level of ADAMTS1 in Granulosa Cells of PCOS Patients Is Related to Granulosa Cell Function, Oocyte Quality, and Embryo Development
Guang Yang, Guidong Yao, Ziwen Xu, et al.
Journal of Medicinal Chemistry
|
September 17, 2021
Discovery of a Novel BCL-X<sub>L</sub> PROTAC Degrader with Enhanced BCL-2 Inhibition
Pratik Pal, Dinesh Thummuri, Dongwen Lv, et al.
Journal of the American Chemical Society
|
August 25, 2022
Discovery of XL01126: A Potent, Fast, Cooperative, Selective, Orally Bioavailable, and Blood-Brain Barrier Penetrant PROTAC Degrader of Leucine-Rich Repeat Kinase 2
Xingui Liu, Alexia F Kalogeropulou, Sofia Domingos, et al.
Aging Cell
|
May 17, 2018
Oxidation resistance 1 is a novel senolytic target
Xin Zhang, Suping Zhang, Xingui Liu, et al.
Cell Chemical Biology
|
February 7, 2023
Piperlongumine conjugates induce targeted protein degradation
Jing Pei, Yufeng Xiao, Xingui Liu, et al.
Nature Communications
|
April 26, 2020
Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity
Yonghan He, Xuan Zhang, Jianhui Chang, et al.
Nature Communications
|
November 26, 2021
Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity
Dongwen Lv, Pratik Pal, Xingui Liu, et al.
Page
of 4